104 related articles for article (PubMed ID: 9546931)
1. Prostanoid drug therapy for peripheral arterial occlusive disease--the European experience.
Dormandy JA
Vasc Med; 1996; 1(2):155-8. PubMed ID: 9546931
[TBL] [Abstract][Full Text] [Related]
2. Two randomised and placebo-controlled studies of an oral prostacyclin analogue (Iloprost) in severe leg ischaemia. The Oral Iloprost in severe Leg Ischaemia Study Group.
Eur J Vasc Endovasc Surg; 2000 Oct; 20(4):358-62. PubMed ID: 11038148
[TBL] [Abstract][Full Text] [Related]
3. Prostanoids in therapy of peripheral arterial occlusive disease.
Creutzig A; Caspary L
Therapie; 1991; 46(3):241-5. PubMed ID: 1792658
[TBL] [Abstract][Full Text] [Related]
4. Epoprostenol (prostacyclin) and severe arterial disease. A double-blind trial.
Belch JJ; McKay A; McArdle B; Leiberman P; Pollock JG; Lowe GD; Forbes CD; Prentice CR
Lancet; 1983 Feb; 1(8320):315-7. PubMed ID: 6130330
[TBL] [Abstract][Full Text] [Related]
5. [Prostacyclin and pentoxifylline in the treatment of patients with inoperable occlusions of the peripheral arteries of the lower extremities].
Maksimović ZV
Srp Arh Celok Lek; 1999; 127(7-8):249-53. PubMed ID: 10624398
[TBL] [Abstract][Full Text] [Related]
6. [Evaluation of cutaneous necrosis risk in peripheral arterial diseases].
D'Eri A; Martini R; Cordova RM; Trevisan G; Andreozzi GM
Minerva Cardioangiol; 2002 Jun; 50(3):239-44. PubMed ID: 12107403
[TBL] [Abstract][Full Text] [Related]
7. A randomized, placebo controlled trial of prostacyclin (PGI2) in peripheral arterial disease.
Hossman V; Heinen A; Auel H; FitzGerald GA
Thromb Res; 1981 May; 22(4):481-90. PubMed ID: 7027528
[No Abstract] [Full Text] [Related]
8. [New data on vasoactive drug. Patients with peripheral arterial occlusive disease walk twice as long].
MMW Fortschr Med; 2002 May; 144(21):54. PubMed ID: 12134429
[No Abstract] [Full Text] [Related]
9. [Vasoactive agents and prostanoids in the therapy of PAD: facts, questions, disproven assumptions].
Heidrich H
Hamostaseologie; 2006 Aug; 26(3):220-3. PubMed ID: 16906239
[TBL] [Abstract][Full Text] [Related]
10. Prostanoids in the treatment of intermittent claudication--a meta-analysis.
Reiter M; Bucek RA; Stümpflen A; Dirisamer A; Minar E
Vasa; 2002 Nov; 31(4):219-24. PubMed ID: 12510544
[TBL] [Abstract][Full Text] [Related]
11. A randomized, double-blind, crossover comparison of iloprost with dextran in patients with peripheral arterial occlusive disease.
Ylitalo P; Kaukinen S; Reinikainen P; Salenius JP; Vapaatalo H
Int J Clin Pharmacol Ther Toxicol; 1990 May; 28(5):197-204. PubMed ID: 1694831
[TBL] [Abstract][Full Text] [Related]
12. [Prostaglandin E1 in intermittent claudication].
Scheffler P; de la Hamette D; Rogatti W
Vasa Suppl; 1992; 35():147-8. PubMed ID: 1481022
[No Abstract] [Full Text] [Related]
13. Clinical effects of intravenous iloprost in patients with intermittent claudication.
Müller-Bühl U; Diehm C; Krais T; Zimmermann R; Mörl H; Eckstein HH
Eur J Clin Pharmacol; 1987; 33(2):127-31. PubMed ID: 2446877
[TBL] [Abstract][Full Text] [Related]
14. [Randomized placebo-controlled studies of iloprost in treatment of lower limb critical ischaemia].
Kharazov AF
Angiol Sosud Khir; 2010; 16(3):27-33. PubMed ID: 21280291
[TBL] [Abstract][Full Text] [Related]
15. [Experiences with solcoseryl in treatment of stage II peripheral arterial occlusive disease--assessment of clinical effectiveness].
Horsch S; Claeys L
Vasa Suppl; 1992; 35():151-2. PubMed ID: 1481024
[No Abstract] [Full Text] [Related]
16. Medical treatment of peripheral vascular disease: good or bad?
Duprez D; Clement DL
Eur Heart J; 1992 Feb; 13(2):149-51. PubMed ID: 1555609
[TBL] [Abstract][Full Text] [Related]
17. Assessment of captopril and nicardipine effects on chronic occlusive arterial disease of the lower extremity using Doppler ultrasound.
Bernardi D; Bartoli P; Ferreri A; Geri AB; Ieri A
Angiology; 1988 Nov; 39(11):942-52. PubMed ID: 3052183
[TBL] [Abstract][Full Text] [Related]
18. Peripheral arterial occlusive disease: conservative treatment of intermittent claudication.
Kriessmann A
J Cardiovasc Pharmacol; 1990; 16 Suppl 3():S72-4. PubMed ID: 1369724
[TBL] [Abstract][Full Text] [Related]
19. [Drug therapy in peripheral arterial occlusive disease].
Bollinger A
Schweiz Med Wochenschr; 1988 Sep; 118(36):1283-9. PubMed ID: 3051339
[TBL] [Abstract][Full Text] [Related]
20. Parenteral therapy with lipo-ecraprost, a lipid-based formulation of a PGE1 analog, does not alter six-month outcomes in patients with critical leg ischemia.
Brass EP; Anthony R; Dormandy J; Hiatt WR; Jiao J; Nakanishi A; McNamara T; Nehler M;
J Vasc Surg; 2006 Apr; 43(4):752-9. PubMed ID: 16616232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
